New and Reemerging Infectious Diseases - A Global Crisis and Immediate Threat to the Nation's Health, The Role of Research
Deaths due to infectious diseases increased 58 percent in the United States from 1982 to 1992. Infectious diseases now rank third in the leading causes of death in the United States. They remain the leading cause of death worldwide. In parallel with an increase in disease due to infectious agents, the United States is experiencing an unprecedented increase in resistance to commonly used antibiotics. Thus, there is an urgent need for the United States to increase its investment in research related to improved diagnosis, treatment and prevention of infectious diseases. The Office of Public Affairs published this booklet to communicate with policy makers and the general public about the threat of new and reemerging infectious diseases and the role of research supported by the National Institutes of Health and the National Institute of Allergy and Infectious Diseases.
A summary of a congressional briefing that was held on June 21, 1999 as a part of the ASM's centennial celebration. The briefing included presentations by some of the nation's most eminent researchers. They discussed threats from infectious diseases and biological terrorism as well as research and strategies to detect, treat and control the resurgence of infectious diseases.
The ASM commissioned The Lewin Group to conduct a survey analysis that investigated the impact of managed care and other health system change on the functions and practices of clinical microbiology laboratories. The study also explores the strategies implemented by laboratories in response to these changes. This report is the first semi-quantitative, objective evaluation of the impact of managed care on the status of clinical microbiology laboratories in a variety of settings, from academic medical centers to community hospitals.